Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 808 Precursor Cell Lymphoblastic Leukemia-Lymphoma 171 Recurrence 141 Neoplasms, Plasma Cell 111 Lymphoma 93 Leukemia 91 Neoplasms 81 Burkitt Lymphoma 57 Vomiting 51 Lymphoma, Non-Hodgkin 50 Immunoglobulin Light-chain Amyloidosis 50 Lymphoma, Large B-Cell, Diffuse 44 Nausea 38 Lymphoma, Mantle-Cell 38 Prostatic Neoplasms 31 Lymphoma, Follicular 30 Hodgkin Disease 29 Waldenstrom Macroglobulinemia 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27 Neoplasm Metastasis 26 Leukemia, Lymphocytic, Chronic, B-Cell 26 Carcinoma, Non-Small-Cell Lung 26 Leukemia, Myeloid, Acute 25 Breast Neoplasms 25 Lung Neoplasms 23 Amyloidosis 21 Leukemia, Biphenotypic, Acute 18 Lymphoma, B-Cell, Marginal Zone 17 Lymphoma, Extranodal NK-T-Cell 16 Smoldering Multiple Myeloma 15

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 21 Radiotherapy 20 pembrolizumab 18 Specimen Handling 17 Cetuximab 16 Biopsy 13 Radiotherapy, Intensity-Modulated 12 Radiation 11 Paclitaxel 11 Carboplatin 11 Surveys and Questionnaires 10 Fluorouracil 10 Drug Therapy 10 1,2-diaminocyclohexaneplatinum II citrate 10 Platinum 9 Surgical Procedures, Operative 8 X-Rays 7 Taxes 7 Celecoxib 7 Standard of Care 6 Sentinel Lymph Node Biopsy 6 Observation 5 Nivolumab 5 cemiplimab 4 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Dexamethasone × Clear all

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡